However, our study has inherent limitations due to the nature of the NCDB, which can have potential miscoding of variables, selection bias that we cannot detect including the location of the tumor in the brain, the size of the tumor, and any complications from surgery, and missing data for some variables, specifically KPS, use of TMZ, and MGMT promoter-methylation status. The gene discussed is MGMT; the disease is neoplasm.